RecallDepth
Class III Ongoing

Fesoterodine Fumarate, Extended-release Tablets, 8 mg, 30 Tablets, Rx only, Manufactured by: Alembic Pharmaceuticals Limited, Panelav 389350, Gujarat, India, Manufactured for: Alembic Pharmaceuticals, Inc., Bedminster, NJ 07921, USA, NDC 62332-176-30

This recall is currently active, issued January 14, 2026. It was issued by Alembic Pharmaceuticals Limited.

Company
Alembic Pharmaceuticals Limited
Recall Initiated
December 16, 2025
Posted
January 14, 2026
Recall Number
D-0248-2026
Voluntary / Mandated
Voluntary: Firm initiated
Firm Location
Panchmahal, India
Official Source
View on FDA website ↗

Reason for Recall

Failed Impurities/Degradation Specifications: Due to levels of 'Diester Impurity' exceeding the specification limit.

Distribution

US Nationwide and PR.

Lot / Code Info

Lot# 2405003360, Exp Date: Jan 31, 2026

More recalls by Alembic Pharmaceuticals Limited

View all recalls by this company →

Other recent Class III Drug recalls